zepbound glp 1 agonist News from the FDA today!! (Tirzepatide) is a GLP-1 that has been approved for weight loss in obese patients (BMI >30) and overweight patients (BMI >27) with at least one GLP-1 Receptor Agonist Retatrutide for Weight Loss:

zepbound glp 1 agonist News from the FDA today!! (Tirzepatide) is a GLP-1 that has been approved for weight loss in obese patients (BMI >30) and overweight patients (BMI >27) with at least one GLP-1 Receptor Agonist Retatrutide for Weight Loss:

Retatrutide for Weight Loss: What It Is, How It Works & Side Effects

What to Expect During Screening If you’re interested in Mounjaro or another GLP-1 receptor agonist, your healthcare provider will likely: Review your medical history : Including any conditions, medications, allergies, and family history

GLP-1 Receptor Agonist

[1] For Hashimoto's patients specifically, there are additional concerns